Skip to main content

Table 4 Adjusted odds ratio of hospital mortality comparing new-onset AF, non-AF and preexisting AF

From: Prognosis and management of new‐onset atrial fibrillation in critically ill patients

Outcomes

Group

Odds ratio

95% CI

p value

Hospital mortality

Crude

Non-AF

Ref

  
 

New-onset AF

1.46

1.32–1.62

< 0.001

Model 1

Non-AF

Ref

  
 

New-onset AF

1.46

1.30–1.64

< 0.001

Model 2

Non-AF

Ref

  
 

New-onset AF

1.61

1.41–1.85

< 0.001

Crude

Preexisting AF

Ref

  
 

New-onset AF

0.88

0.77–0.99

0.029

Model 1

Preexisting AF

Ref

  
 

New-onset AF

1.31

1.15–1.49

< 0.001

Model 2

Preexisting AF

Ref

  
 

New-onset AF

1.17

1.01–1.35

0.034

  1. Model 1 was adjusted by: age, gender, type of intensive care unit, hypertension, diabetes, coronary heart diseases, congestive heart failure, hyperlipidemia, chronic obstructive pulmonary disease (COPD), cerebral infarction, pulmonary embolism, sepsis, and hypothyroidism; Model 2 was adjusted by: except variables in model 1, the following have been added: Sequential Organ Failure Assessment(SOFA) score, laboratory tests performed on admission, including white blood cells (WBC), hemoglobin (HB), serum creatinine (Scr), and medications during hospitalization, including β blockers, statin, amiodarone, Non-dihydropyridine calcium channel blocker (CCB), digoxin, warfarin
  2. AF atrial fibrillation, Ref reference